Affinivax's 24-Valent Pneumococcal Vaccine Targets Growing And Changing Market

Market Competitors Include Pfizer And Merck & Co

 
• By John Davis
  
pneumococcal bacteria
Pneumococcal Bacteria, Streptococcus pneumoniae • Source: Alamy

More from Clinical Trials

More from R&D